Small cell lymphoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Small cell lymphocytic leukemia; SLL

Overview[edit | edit source]

Small cell lymphoma (also known as SLL) is a type of mature B-cell chronic lymphocytic leukemia that presents primarily in the lymph nodes. In 1924, small cell lymphoma was first discovered by the American physician Dr. George Minot.^[1] There is no standardized classification system for small cell lymphoma. The pathogenesis of small cell lymphoma is characterized by the malignant infiltration of lymphocytic cells into the bone marrow where they interfere with the production of other hematopoeitic cell lines such as red blood cells and platelets. Small cell lymphoma arises from pre-follicular center B cells that are normally involved in the process of human immunoglobulins production. Small cell lymphoma represents 90 % of all B-cell chronic lymphocytic leukemias in the United States. Small cell lymphoma presents at a median age of 65 years. Males are slightly more affected with small cell lymphoma than females. Symptoms of small cell lymphoma may include fever,weight loss, generalized weakness, anorexia, and night sweats. The mainstay therapy of small cell lymphoma is chemotherapy and radiotherapy.

Historical Perspective[edit | edit source]

In 1924, small cell lymphoma was first discovered by the American physician Dr. George Minot.^[1]

Classification[edit | edit source]

There is no classification system for small cell lymphoma.^[2] Small cell lymphoma is a subtype of of B-cell chronic lymphocytic leukemia.

Pathophysiology[edit | edit source]

Pathogenesis[edit | edit source]

• The pathogenesis of small cell lymphoma is characterized by the malignant infiltration of lymphocytic cells into the bone marrow, where they interfere with the production of red blood cells and platelets.
• Small cell lymphoma arises from pre-follicular center B cells that are normally involved in the process of human immunoglobulins production.

Genetics[edit | edit source]

Genes involved in the development of small cell lymphoma include:

• Chromosome 11 long arm deletion
• Chromosome 13 long arm deletion (most common genetic mutation)
• Chromosome 17 short arm deletion
• Trisomy 12

Gross Pathology[edit | edit source]

There are no remarkable gross pathological findings in small cell lymphoma.

Microscopic Pathology[edit | edit source]

On microscopic histopathological analysis, characteristic findings of small cell lymphoma include:

• Small lymphoid cells
• Thin cytoplasmic border
• Dense nucleus
• Lack of nucleolus
• Clumped chromatin aggregates
• The presence of smudge cells
• The presence of gumprecht nuclear shadows

On immunohistopathological analysis, characteristic findings of small cell lymphoma may include:

• CD19
• CD20
• CD23
• CD5

Causes[edit | edit source]

There are no established causes for small cell lymphoma.

Differentiating Small Cell Lymphoma from Other Diseases[edit | edit source]

Small cell lymphoma must be differentiated from other diseases that cause fever, anorexia, and weakness such as:^[3]

• Anemia
• Plasma cell neoplasm
• Hairy cell leukemia
• Mantle cell lymphoma

Epidemiology and Demographics[edit | edit source]

Prevalence[edit | edit source]

The prevalence of small cell lymphoma is low. Small cell lymphoma represents 90 % of all B-cell chronic lymphocytic leukemias in the United States.^[3]

Age[edit | edit source]

The median age at diagnosis is 65 years.

Gender[edit | edit source]

Males are more commonly affected with small cell lymphoma than females.

Race[edit | edit source]

There is no racial predilection for small cell lymphoma.

Risk Factors[edit | edit source]

The risk factors for the development of small cell lymphoma are not well established. The most consistent risk factor is a family history of non-hodgkins lymphoma.^[4]

Natural History, Complications and Prognosis[edit | edit source]

Natural History[edit | edit source]

The majority of patients with small cell lymphoma are symptomatic. Early clinical features include generalized weakness, anorexia, and night sweats. If left untreated, patients with small cell lymphoma may progress to develop recurrent infections.

Complications[edit | edit source]

Common complications of small cell lymphoma include:^[3]

• Severe immunodeficiency
• Warm autoimmune hemolytic anemia
• Richter's transformation

Prognosis[edit | edit source]

The prognosis of small cell lymphoma is generally poor; the 5-year survival rate of patients with small cell lymphoma is approximately 51-67%.^[3]

Diagnosis[edit | edit source]

Symptoms[edit | edit source]

Symptoms of small cell lymphoma may include the following:

• Fever
• Weight loss
• Muscle wasting
• Generalized weakness
• Anorexia
• Night sweats

Physical Examination[edit | edit source]

Patients with small cell lymphoma often appear pale and malnourished. Physical examination may be remarkable for:

• Pallor
• Petechiae
• Leukemia cutis (infiltration of neoplastic leukocytes or their precursors into the skin resulting in clinically identifiable cutaneous lesions)
• Enlarged and palpable cervical lymph nodes
• Dacryoadenitis

Laboratory Findings[edit | edit source]

Laboratory findings consistent with the diagnosis of small cell lymphoma include:^[5]

• Absolute lymphocytosis (>5000 cells/μl)^[6][7]
• Decreased hemoglobin concentration
• Decreased platelets count

Imaging Findings[edit | edit source]

There are no specific imaging findings associated with small cell lymphoma. CT scan may be helpful in the diagnosis small cell lymphoma, findings may include enlarged lymph nodes (>2 cm).

Treatment[edit | edit source]

Medical Therapy[edit | edit source]

The mainstay of therapy for small cell lymphoma is chemotherapy and radiotherapy.

Surgery[edit | edit source]

Surgery is not recommended among patients with small cell lymphoma.^[3]

• The diagnosis of small cell lymphoma is made with a excisional lymph node biopsy combined with a bone marrow biopsy.

Prevention[edit | edit source]

Primary Prevention[edit | edit source]

There are no primary preventive measures available for small cell lymphoma.

Secondary Prevention[edit | edit source]

Secondary prevention strategies following small cell lymphoma include follow up every 6 to 12 months. Follow-up testing includes a complete blood count and physical examination.

References[edit | edit source]

Template:WH Template:WS